BridgeMD
Comparative clinical trial of efficacy and satisfaction of 2% gel lidocaine versus tetracaine/oxybuprocaine anesthetic eye drops in patients undergoing needing techniques in ophthalmology consultations. Anesthesia in Needling with Lidocaine (ANELI)
EU CTIS ID: 2023-505131-13-01
What this study is testing
To compare the anesthetic efficacy of 2% lidocaine gel with colirofta double anesthetic 1 mg/ml tetracaine hydrochloride + 4 mg/ml oxybuprocaine hydrochloride eye drops in solution in the in-office needling procedure
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients operated on glaucoma surgery with filtration ampoule who require the needling procedure in consultation
- Over 18 years of age, who have understood and signed the informed consent.
You likely can't join if
- Pregnant or breastfeeding patients
- Patients who require needling in the operating room
- Patients with cognitive impairment who do not understand the numerical rating scale in pain
- Hearing loss that prevents patient collaboration
- Anxiety disorder that prevents patient collaboration
- Allergy to lidocaine, oxybuprocaine, or tetracaine
See the full eligibility criteria
- Patients operated on glaucoma surgery with filtration ampoule who require the needling procedure in consultation
- Over 18 years of age, who have understood and signed the informed consent.
- Pregnant or breastfeeding patients
- Patients who require needling in the operating room
- Patients with cognitive impairment who do not understand the numerical rating scale in pain
- Hearing loss that prevents patient collaboration
- Anxiety disorder that prevents patient collaboration
- Allergy to lidocaine, oxybuprocaine, or tetracaine
- Patients who require needling in the operating room
- Hypersensitivity to ester-type local anesthetics, other para aminobenzoic acid derivatives or to any of the excipients of Colirofta
- Hypersensitivity to other amide-type local anesthetics or to any of the excipients of Ophtesic
- Hypersensitivity to hypromelose gel
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.